Otolaryngology - Head and Neck Surgery·New York, NY

NYU Grossman School of Medicine

Signal lift4%38%+34 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
248–273
p10 – p90
Sample N
276
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.4%
4 of 47 applicants
01Cohort funnelthis cycle
N = 276
Applied
276
100.0%
Invited
47
17%
Class size
4
1.4%
J-1 visaCategorical
Your fitNYU Grossman School of Medicine Program

Create a free profile to see your personalized fit

Get started
Contact
RL
Program Director
Richard A Lebowitz, MD
Email director
RG
Program Coordinator
Rosanna Gutierrez
Email coordinator
Training sites5 hospitals · New York
  • 1
    NYU Grossman School of Medicine
    New York, NY
    Primary
  • 2
    NYC Health + Hospitals/Bellevue
    New York, NY
    Participant
  • 3
    Lenox Hill Hospital-Northwell Health
    New York, NY
    Participant
  • 4
    Manhattan VA Harbor Health Care System
    New York, NY
    Participant
  • 5
    NYU Langone Hospitals
    New York, NY
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK248273
180205230255280

Level 2 CE data not available

Interview rates
US MD
20%
US DO
0%
US IMG
0%
Non-US IMG
0%
Applicant origin
In-state
39%
Out-of-state
13%
Interview prepOtolaryngology - Head and Neck Surgery
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add NYU Grossman School of Medicine to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Otolaryngology - Head and Neck Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.